Naz News, Gappers and FLE's

[CABRALEES]

INSM found this on the INSM thread.....

From http://www.antandsons.com/2007/02/insmed-settlement-speculation-drives.html

February 27, 2007
Insmed Settlement Speculation Drives Shares

We were surprised to find a stock moving to the upside today, as there are not that many given the broader market decline, but Insmed Inc. (NASDAQ: INSM) fits the bill. Here is what we know. Insmed, the manufacture of Iplex, has been found to infringe patents licensed by Tercica, the maker of a rival drug. Tercica is currently working to get a federal judge to ban sales of Iplex. Although Tercica's drug will be available, it requires two injections a day instead of one and some doctors say it may be less safe. Doctors also say that Iplex has other uses and might even be instrumental in treating not only growth deficiency, but also Lou Gehrig's disease, burns, eye diseases, adult muscular dystrophy and the side effects of H.I.V. medications. Last week, it was reported that a hearing in Federal District Court in Oakland, Calif., at which Judge Claudia Wilken was to rule on Iplex was postponed. This has sparked rumors that the two companies might be trying to work out a last minute settlement. With recent New York Times coverage adding attention to Insmed shares, the stock has gotten a lift. In mid-day trading, Insmed is higher by $.11, or 8.73%, to $1.37 on heavy volume of 5.1 million shares compared to daily average volume of 3.2 million shares. We have tried to follow up on the story, but Jody LoMenzo, Director of Corporate Communications, could not be reached for comment.
by Thomas @ 1:15 PM | 0 replies | E-mail | RSS
Link to: Del.icio.us | Digg | Technorati